128 related articles for article (PubMed ID: 10930683)
1. Aluminium phosphate adjuvants prepared by precipitation at constant pH. Part II: physicochemical properties.
Burrell LS; Johnston CT; Schulze D; Klein J; White JL; Hem SL
Vaccine; 2000 Sep; 19(2-3):282-7. PubMed ID: 10930683
[TBL] [Abstract][Full Text] [Related]
2. Aluminium phosphate adjuvants prepared by precipitation at constant pH. Part I: composition and structure.
Burrell LS; Johnston CT; Schulze D; Klein J; White JL; Hem SL
Vaccine; 2000 Sep; 19(2-3):275-81. PubMed ID: 10930682
[TBL] [Abstract][Full Text] [Related]
3. Stability of aluminium-containing adjuvants to autoclaving.
Burrell LS; Lindblad EB; White JL; Hem SL
Vaccine; 1999 Jun; 17(20-21):2599-603. PubMed ID: 10418908
[TBL] [Abstract][Full Text] [Related]
4. Stability of aluminium-containing adjuvants during aging at room temperature.
Burrell LS; White JL; Hem SL
Vaccine; 2000 Apr; 18(21):2188-92. PubMed ID: 10717337
[TBL] [Abstract][Full Text] [Related]
5. Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants.
al-Shakhshir R; Regnier F; White JL; Hem SL
Vaccine; 1994 Apr; 12(5):472-4. PubMed ID: 8023556
[TBL] [Abstract][Full Text] [Related]
6. Using rate of acid neutralization to characterize aluminum phosphate adjuvant.
Jiang D; Johnston CT; Hem SL
Pharm Dev Technol; 2003; 8(4):349-56. PubMed ID: 14601959
[TBL] [Abstract][Full Text] [Related]
7. Analysis of aluminum hydroxyphosphate vaccine adjuvants by (27)Al MAS NMR.
Klein J; Ushio M; Burrell LS; Wenslow B; Hem SL
J Pharm Sci; 2000 Mar; 89(3):311-21. PubMed ID: 10707012
[TBL] [Abstract][Full Text] [Related]
8. Predicting the adsorption of proteins by aluminium-containing adjuvants.
Seeber SJ; White JL; Hem SL
Vaccine; 1991 Mar; 9(3):201-3. PubMed ID: 2042392
[TBL] [Abstract][Full Text] [Related]
9. Stabilised aluminium phosphate nanoparticles used as vaccine adjuvant.
Vrieling H; Espitia Ballestas M; Hamzink M; Willems GJ; Soema P; Jiskoot W; Kersten G; Metz B
Colloids Surf B Biointerfaces; 2019 Sep; 181():648-656. PubMed ID: 31212137
[TBL] [Abstract][Full Text] [Related]
10. Treatment of aluminium hydroxide adjuvant to optimize the adsorption of basic proteins.
Rinella JV; White JL; Hem SL
Vaccine; 1996 Mar; 14(4):298-300. PubMed ID: 8744556
[TBL] [Abstract][Full Text] [Related]
11. Methods to Prepare Aluminum Salt-Adjuvanted Vaccines.
Thakkar SG; Cui Z
Methods Mol Biol; 2017; 1494():181-199. PubMed ID: 27718194
[TBL] [Abstract][Full Text] [Related]
12. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
DePaz RA; Henderson I; Advant SJ
Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
[TBL] [Abstract][Full Text] [Related]
13. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
[TBL] [Abstract][Full Text] [Related]
14. Characterization of aluminium-containing adjuvants.
White JL; Hem SL
Dev Biol (Basel); 2000; 103():217-28. PubMed ID: 11214239
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.
Levesque PM; de Alwis U
Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824
[TBL] [Abstract][Full Text] [Related]
16. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines.
Shi Y; HogenEsch H; Hem SL
Vaccine; 2001 Oct; 20(1-2):80-5. PubMed ID: 11567749
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting alum-protein interactions.
Huang M; Wang W
Int J Pharm; 2014 May; 466(1-2):139-46. PubMed ID: 24607202
[TBL] [Abstract][Full Text] [Related]
18. Structure and properties of aluminum-containing adjuvants.
Hem SL; White JL
Pharm Biotechnol; 1995; 6():249-76. PubMed ID: 7551220
[TBL] [Abstract][Full Text] [Related]
19. Physico-chemical investigation of AlPO4 for the manufacture of antacids. I. Effect of precipitation and processing conditions on physico-chemical properties of AlPO4.
Umbreit MH
Pol J Pharmacol Pharm; 1978; 30(1):119-23. PubMed ID: 25424
[TBL] [Abstract][Full Text] [Related]
20. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
Hem SL; Hogenesch H
Expert Rev Vaccines; 2007 Oct; 6(5):685-98. PubMed ID: 17931150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
